Jakafi 15 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DR26FCRG5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,986
Award facts
- Contract value 100% obligated
- $48,986.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $48,986.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 60 tablets of Jakafi 15 mg. The delivery order was issued on November 4, 2025, with a completion date of November 5, 2025, under firm fixed-price terms with no set-aside designation. This award represents one of numerous delivery orders DMS Pharmaceutical Group has received from the Defense Logistics Agency's Medical Supply Chain division, demonstrating the company's competitive capability in unrestricted federal pharmaceutical procurement.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support recurring medical supply needs of military healthcare facilities worldwide. DMS Pharmaceutical Group's PPV-G GEN V prime vendor contract, valued at $499,999,999 with a completion date of December 31, 2036, authorizes the company to supply a comprehensive range of branded and generic pharmaceuticals, over-the-counter medications, biologics, and medical consumables to Department of Defense healthcare operations globally. The company's substantial federal contracting activity across multiple therapeutic categories reflects its established performance as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FCRG5?
SPE2DR26FCRG5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DR26FCRG5 worth?
The government has obligated $48,986 on SPE2DR26FCRG5.
Is contract SPE2DR26FCRG5 an order under another contract?
Yes. SPE2DR26FCRG5 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCRG5 competed?
The extent of competition for SPE2DR26FCRG5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award